GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nova Eye Medical Ltd (OTCPK:ELXMF) » Definitions » Gross Profit

Nova Eye Medical (Nova Eye Medical) Gross Profit : $11.35 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Nova Eye Medical Gross Profit?

Nova Eye Medical's gross profit for the six months ended in Dec. 2023 was $5.98 Mil. Nova Eye Medical's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $11.35 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Nova Eye Medical's gross profit for the six months ended in Dec. 2023 was $5.98 Mil. Nova Eye Medical's Revenue for the six months ended in Dec. 2023 was $6.79 Mil. Therefore, Nova Eye Medical's Gross Margin % for the quarter that ended in Dec. 2023 was 88.11%.

Nova Eye Medical had a gross margin of 88.11% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Nova Eye Medical was 90.24%. The lowest was 50.84%. And the median was 60.11%.


Nova Eye Medical Gross Profit Historical Data

The historical data trend for Nova Eye Medical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Eye Medical Gross Profit Chart

Nova Eye Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.28 6.73 8.53 7.97 9.66

Nova Eye Medical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 5.22 4.31 5.37 5.98

Competitive Comparison of Nova Eye Medical's Gross Profit

For the Medical Devices subindustry, Nova Eye Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Eye Medical's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Nova Eye Medical's Gross Profit falls into.



Nova Eye Medical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Nova Eye Medical's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=11.426 - 1.766
=9.66

Nova Eye Medical's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=6.786 - 0.807
=5.98

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $11.35 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Nova Eye Medical's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=5.98 / 6.786
=88.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Nova Eye Medical  (OTCPK:ELXMF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Nova Eye Medical had a gross margin of 88.11% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Nova Eye Medical Gross Profit Related Terms

Thank you for viewing the detailed overview of Nova Eye Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Eye Medical (Nova Eye Medical) Business Description

Traded in Other Exchanges
Address
107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067
Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.

Nova Eye Medical (Nova Eye Medical) Headlines